High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma

[1]  L. YuAlice,et al.  Alterations of Glycosphingolipids in Embryonic Stem Cell Differentiation and Development of Glycan-Targeting Cancer Immunotherapy , 2016 .

[2]  John Yu,et al.  Fucosylation of LAMP-1 and LAMP-2 by FUT1 correlates with lysosomal positioning and autophagic flux of breast cancer cells , 2016, Cell Death and Disease.

[3]  John Yu,et al.  Alterations of Glycosphingolipids in Embryonic Stem Cell Differentiation and Development of Glycan-Targeting Cancer Immunotherapy. , 2016, Stem cells and development.

[4]  Chi‐Huey Wong,et al.  Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells , 2015, Proceedings of the National Academy of Sciences.

[5]  A. Schneeweiss,et al.  The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features , 2015, Breast Cancer Research.

[6]  A. Schneeweiss,et al.  The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features , 2015, Breast Cancer Research.

[7]  S. Pinho,et al.  Glycosylation in cancer: mechanisms and clinical implications , 2015, Nature Reviews Cancer.

[8]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[9]  A. Koch,et al.  A key role for Fut1-regulated angiogenesis and ICAM-1 expression in K/BxN arthritis , 2014, Annals of the rheumatic diseases.

[10]  K. Yeh,et al.  Globo-H ceramide shed from cancer cells triggers translin-associated factor X-dependent angiogenesis. , 2014, Cancer research.

[11]  T. Sørlie,et al.  Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft , 2014, PloS one.

[12]  A. Cucchetti,et al.  Prognostic factors for hepatocellular carcinoma recurrence. , 2014, World journal of gastroenterology.

[13]  R. Wirtz,et al.  Prognostic relevance of glycosylation-associated genes in breast cancer , 2014, Breast Cancer Research and Treatment.

[14]  Chung-Yi Wu,et al.  Downregulation of microRNA‐15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2‐induced Globo H expression , 2014, International journal of cancer.

[15]  Hwee Tong Tan,et al.  Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects. , 2014, World journal of gastroenterology.

[16]  Kay-Hooi Khoo,et al.  Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers , 2014, Proceedings of the National Academy of Sciences.

[17]  Z. Wang,et al.  Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[18]  Hee-Jung Choi,et al.  Hepatitis B virus X protein specially regulates the sialyl lewis a synthesis among glycosylation events for metastasis , 2014, Molecular Cancer.

[19]  C. Koike,et al.  CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics. , 2013, Oral oncology.

[20]  K. Yeh,et al.  A Prevalent Cancer Associated Glycan, Globo H Ceramide, Induces Immunosuppression by Reducing Notch1 Signaling , 2013 .

[21]  H. Ishii,et al.  SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers. , 2012, International journal of oncology.

[22]  Lixin Wei,et al.  Mesenchymal Stem Cells in Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition , 2012, PloS one.

[23]  A. Warth,et al.  Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis , 2012, European Respiratory Journal.

[24]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[25]  K. Khoo,et al.  Changes in Glycosphingolipid Composition During Differentiation of Human Embryonic Stem Cells to Ectodermal or Endodermal Lineages , 2011, Stem cells.

[26]  K. Jung,et al.  Inhibition of ganglioside GD1a synthesis suppresses the differentiation of human mesenchymal stem cells into osteoblasts , 2011, Development, growth & differentiation.

[27]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[28]  Lewis R. Roberts,et al.  Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.

[29]  Cai-yun Zhou,et al.  Stage-Specific Embryonic Antigen 4 Expression in Epithelial Ovarian Carcinoma , 2010, International Journal of Gynecologic Cancer.

[30]  J. Bruix,et al.  A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma , 2010, Hepatology.

[31]  Wei Zhao,et al.  The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. , 2010, Carcinogenesis.

[32]  J. Prieto,et al.  The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer , 2009, Experimental biology and medicine.

[33]  M. Linnebacher,et al.  Hep G2 is a hepatoblastoma-derived cell line , 2009 .

[34]  K Ann McKibbon,et al.  Current status and future prospects. , 2008, Health information and libraries journal.

[35]  Jyh‐cherng Yu,et al.  Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis , 2008, Proceedings of the National Academy of Sciences.

[36]  Chung-Yi Wu,et al.  Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer , 2008, Proceedings of the National Academy of Sciences.

[37]  Lihua Yu,et al.  Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growth. , 2008, Biochimica et biophysica acta.

[38]  S. Mathieu,et al.  Introducing α(1,2)‐linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth , 2007 .

[39]  S. Mathieu,et al.  Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth. , 2007, International journal of cancer.

[40]  Samara L. Lewis,et al.  Definitive endoderm of the mouse embryo: Formation, cell fates, and morphogenetic function , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[41]  P. Smaglik.  A global view , 2005, Nature.

[42]  C. Bertozzi,et al.  Glycans in cancer and inflammation — potential for therapeutics and diagnostics , 2005, Nature Reviews Drug Discovery.

[43]  R. Kannagi,et al.  Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis , 2004, Cancer science.

[44]  T. Muramatsu,et al.  Carbohydrate antigens expressed on stem cells and early embryonic cells , 2004, Glycoconjugate Journal.

[45]  M. Monden,et al.  Association between Expression Levels of CA 19-9 and N-Acetylglucosamine-β1,3-Galactosyltransferase 5 Gene in Human Pancreatic Cancer Tissue , 2003, Pathobiology.

[46]  T. Wada,et al.  Human α2,3-Sialyltransferase (ST3Gal II) Is a Stage-specific Embryonic Antigen-4 Synthase* , 2003, Journal of Biological Chemistry.

[47]  M. Mareel,et al.  Monosialyl‐Gb5 organized with cSrc and FAK in GEM of human breast carcinoma MCF‐7 cells defines their invasive properties , 2002, FEBS letters.

[48]  S. Hakomori,et al.  Glycosylation defining cancer malignancy: New wine in an old bottle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  David F. Smith,et al.  Special Considerations for Glycolipids and Their Purification , 1993, Current protocols in molecular biology.

[50]  E. Berger,et al.  The β1,3-Galactosyltransferase β3GalT-V Is a Stage-specific Embryonic Antigen-3 (SSEA-3) Synthase* , 2000, The Journal of Biological Chemistry.

[51]  S. Marionneau,et al.  α1,2Fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cells , 2000 .

[52]  J. Le Pendu,et al.  alpha1,2Fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cells. , 2000, Glycobiology.

[53]  E. Berger,et al.  The beta 1,3-galactosyltransferase beta 3GalT-V is a stage-specific embryonic antigen-3 (SSEA-3) synthase. , 2000, The Journal of biological chemistry.

[54]  T. Andoh,et al.  Cloning, Expression, and Characterization of a Novel UDP-galactose:β-N-Acetylglucosamine β1,3-Galactosyltransferase (β3Gal-T5) Responsible for Synthesis of Type 1 Chain in Colorectal and Pancreatic Epithelia and Tumor Cells Derived Therefrom* , 1999, The Journal of Biological Chemistry.

[55]  R. Hogan.  New Wine for the Old Bottle. , 1998 .

[56]  C. Cordon-Cardo,et al.  Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides , 1997, International journal of cancer.

[57]  C. Ohyama,et al.  Expression of Globo‐series Gangliosides in Human Renal Cell Carcinoma , 1997, Japanese journal of cancer research : Gann.

[58]  J. Le Pendu,et al.  Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2) fucosyltransferase gene transfection. , 1997, Glycobiology.

[59]  H. Cooper,et al.  Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[60]  S. Sell,et al.  Environmental Health Perspectives 101(Suppl 5): 15-26 (1993) Cellular Origin of Cancer: Dedifferentiation or Stem Cell Maturation , 2022 .

[61]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[62]  S. Hakomori,et al.  Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. , 1984, The Journal of biological chemistry.

[63]  Ionel Ciucanu,et al.  A simple and rapid method for the permethylation of carbohydrates , 1984 .

[64]  D. Solter,et al.  Stage‐specific embryonic antigens (SSEA‐3 and ‐4) are epitopes of a unique globo‐series ganglioside isolated from human teratocarcinoma cells. , 1983, The EMBO journal.